Insulin resistance is associated with higher cerebrospinal fluid tau levels in asymptomatic APOE epsilon4 carriers

Manuscript Number: 

15-0072R1

Author(s): 
Rozalyn Anderson, Sanjay Asthana, Barbara B. Bendlin, Kaj Blennow, Cynthia M. Carlsson, Nancy J. Davenport-Sis, LeAnn M. DeRungs, N. Maritza Dowling, Carey E. Gleason, Siobhan M. Hoscheidt, Sterling C. Johnson, Patrick O'Grady, Ozioma C. Okonkwo, Luigi Puglielli, Annie M. Racine, Mark A. Sager, Erika J. Starks, Henrik Zetterberg

Disclosures

Rozalyn Anderson

  • Nothing to Disclose

Sanjay Asthana

  • Grants
    • Agency: 
      Merck Pharmaceuticals
      Dates: 
      2014 - present
    • Agency: 
      Lundbeck Pharmaceuticals
      Dates: 
      20014 - Present
    • Agency: 
      Toyoma Pharmaceuticals
      Dates: 
      2014 - Present

Barbara B. Bendlin

  • Nothing to Disclose

Kaj Blennow

  • Nothing to Disclose

Cynthia M. Carlsson

  • Nothing to Disclose

Nancy J. Davenport-Sis

  • Nothing to Disclose

LeAnn M. DeRungs

  • Nothing to Disclose

N. Maritza Dowling

  • Nothing to Disclose

Carey E. Gleason

  • Nothing to Disclose

Siobhan M. Hoscheidt

  • Nothing to Disclose

Sterling C. Johnson

  • Nothing to Disclose

Patrick O'Grady

  • Nothing to Disclose

Ozioma C. Okonkwo

  • Nothing to Disclose

Luigi Puglielli

  • Nothing to Disclose

Annie M. Racine

  • Nothing to Disclose

Mark A. Sager

  • Nothing to Disclose

Erika J. Starks

  • Nothing to Disclose

Henrik Zetterberg

  • Nothing to Disclose